Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions.

Matthew R Bong, Edward L Capla, Kenneth A Egol, Anthony T Sorkin, Michael Distefano, Rosemary Buckle, Robert W Chandler, Kenneth J Koval
{"title":"Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions.","authors":"Matthew R Bong,&nbsp;Edward L Capla,&nbsp;Kenneth A Egol,&nbsp;Anthony T Sorkin,&nbsp;Michael Distefano,&nbsp;Rosemary Buckle,&nbsp;Robert W Chandler,&nbsp;Kenneth J Koval","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A prospective study was conducted to determine the efficacy of using recombinant BMP-7 (rhOP-1) as an adjuvant in the treatment of diaphyseal humeral nonunions. Twenty-three consecutive patients with atrophic humeral diaphyseal nonunions were treated at seven separate institutions. All nonunions were fixed with either a compression plate or an intramedullary nail in conjunction with various bone grafting techniques. Recombinant OP-1 was delivered to the fracture site in a Type I collagen carrier at the time of fixation. All fractures went on to eventual union. There were no serious complications and no adverse reactions to the rhOP-I implant. Our study suggests that rhOP-1 may be a safe and effective adjuvant for the treatment of humeral diaphyseal nonunions.</p>","PeriodicalId":77050,"journal":{"name":"Bulletin (Hospital for Joint Diseases (New York, N.Y.))","volume":"63 1-2","pages":"20-3"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin (Hospital for Joint Diseases (New York, N.Y.))","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A prospective study was conducted to determine the efficacy of using recombinant BMP-7 (rhOP-1) as an adjuvant in the treatment of diaphyseal humeral nonunions. Twenty-three consecutive patients with atrophic humeral diaphyseal nonunions were treated at seven separate institutions. All nonunions were fixed with either a compression plate or an intramedullary nail in conjunction with various bone grafting techniques. Recombinant OP-1 was delivered to the fracture site in a Type I collagen carrier at the time of fixation. All fractures went on to eventual union. There were no serious complications and no adverse reactions to the rhOP-I implant. Our study suggests that rhOP-1 may be a safe and effective adjuvant for the treatment of humeral diaphyseal nonunions.

成骨蛋白-1(骨形态发生蛋白-7)联合各种辅助物治疗肱骨骨干骨不连。
进行了一项前瞻性研究,以确定使用重组BMP-7 (rhOP-1)作为辅助治疗骨干肱骨不连的疗效。连续23例萎缩性肱骨骨干骨不连患者在7个不同的机构接受治疗。所有骨不连均采用加压钢板或髓内钉结合各种植骨技术进行固定。在固定时,重组OP-1在I型胶原载体中被递送到骨折部位。所有的裂痕最终都愈合了。rhop - 1种植体无严重并发症,无不良反应。我们的研究表明rhOP-1可能是治疗肱骨骨干不连的一种安全有效的辅助疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信